EMA — authorised 9 March 2000
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Azopt in European Union
EMA authorised Azopt on 9 March 2000
Marketing authorisation
Azopt in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Azopt approved in European Union?
Yes. EMA authorised it on 9 March 2000.
Who is the marketing authorisation holder for Azopt in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.